Public sector opportunity TRI recently secured a large NIH contract and has a history of engaging with public sector sponsors, indicating strong potential for expanded government and large grant-funded programs in drug development, vaccines, and health-related trials.

Contract research focus As a full service CRO+ with capabilities spanning clinical development, information technology, and communication services, TRI can offer end-to-end support to sponsors seeking integrated outsourcing solutions, including data management, statistical analysis, regulatory consulting, and digital trial platforms.

Growth and scale With revenue in the mid hundreds of millions and recognition as a fast-growing, diverse-owned company, TRI can be positioned to handle increasing trial complexity and global deployments for mid- to large-scale programs.

Technology stack leverage TRI utilizes SAS, Azure, Salesforce, SharePoint, OneTrust, Box and other enterprise tools, suggesting opportunities to upsell advanced analytics, data security, cloud-based collaboration, and regulatory compliance solutions to optimize trial operations.

Diverse market appeal As a Hispanic woman-owned CRO with a global footprint and repeat business, TRI can be targeted for partnerships with sponsors seeking diverse suppliers, inclusive innovation, and quality-focused vendors across pharmaceutical, biologic, vaccine, and medical device programs.